Fortrea (NASDAQ:FTRE) Hits New 52-Week High After Earnings Beat

Fortrea Holdings Inc. (NASDAQ:FTRE) reached a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $21.12 and last traded at $20.70, with a volume of 3237937 shares. The stock had previously closed at $19.20.

The company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.05. The company had revenue of $678.20 million during the quarter, compared to the consensus estimate of $647.57 million. Fortrea had a positive return on equity of 10.72% and a negative net margin of 3.18%.

Key Stories Impacting Fortrea

Here are the key news stories impacting Fortrea this week:

• Positive Sentiment: Fortrea reported second-quarter adjusted earnings of $0.23 per share, exceeding the $0.18 analyst consensus, while revenue of $678.2 million topped expectations of $647.6 million. Earnings also increased from $0.19 per share a year earlier. Fortrea Q2 Earnings Beat
• Positive Sentiment: The company raised or increased its full-year outlook, forecasting 2026 revenue of approximately $2.62 billion to $2.69 billion. Management highlighted four consecutive quarters of improved commercial, operational and financial execution, supporting the bullish case. Fortrea Reports Second Quarter 2026 Results
• Positive Sentiment: Truist Financial raised its price target on Fortrea from $19 to $26 and upgraded the stock to “Buy,” implying substantial potential upside from recent trading levels. The change reflects increased confidence following the earnings results and guidance. Truist Raises Fortrea Price Target
• Neutral Sentiment: Fortrea’s positive quarterly performance was accompanied by a negative net margin, indicating that profitability remains uneven despite the adjusted earnings beat. Analysts currently expect approximately $0.80 in earnings per share for the full fiscal year. Fortrea Earnings Report
• Negative Sentiment: The board appointed director David Smith as interim chief financial officer amid an ongoing legal dispute involving former CFO Michael Madlock and a related covenant proceeding. The management transition and legal uncertainty could weigh on investor confidence and partially offset the strong operating results. Fortrea Names Interim CFO

Wall Street Analyst Weigh In

Several brokerages recently weighed in on FTRE. TD Cowen reaffirmed a “buy” rating on shares of Fortrea in a research note on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $20.00 price target on shares of Fortrea in a research report on Thursday. Robert W. Baird set a $23.00 price target on shares of Fortrea in a research note on Thursday. Citigroup upped their price objective on Fortrea from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Zacks Research upgraded Fortrea from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in Fortrea by 494.8% during the 2nd quarter. AQR Capital Management LLC now owns 6,515,124 shares of the company’s stock worth $31,729,000 after acquiring an additional 5,419,842 shares in the last quarter. Park West Asset Management LLC purchased a new stake in shares of Fortrea in the 3rd quarter valued at approximately $18,579,000. Iron Triangle Partners LP acquired a new stake in shares of Fortrea in the 4th quarter valued at $34,264,000. MetLife Investment Management LLC raised its holdings in shares of Fortrea by 2,328.5% in the 4th quarter. MetLife Investment Management LLC now owns 1,368,656 shares of the company’s stock valued at $23,609,000 after purchasing an additional 1,312,297 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Fortrea by 163.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,299,862 shares of the company’s stock worth $12,241,000 after purchasing an additional 807,081 shares during the last quarter.

Fortrea Trading Down 6.5%

The company has a debt-to-equity ratio of 1.98, a quick ratio of 0.95 and a current ratio of 0.96. The company’s 50-day moving average price is $16.93 and its 200-day moving average price is $13.80. The firm has a market capitalization of $1.80 billion, a PE ratio of -20.97, a PEG ratio of 0.62 and a beta of 2.03.

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.